TrialsgrambetaRCTs are beautiful
ESC Congress 2026Presentato lun 31 ago · 13:00 CESTHot Line 11Tutti gli studi Hot Line →

EVAOLD

2026

Evaluation of a Strategy Guided by Imaging Versus Systematic Coronary Angiography in Elderly Patients With Ischemia: a Multicentric Randomized Non Inferiority Trial (EVAOLD)

In 587 patients aged 80 years or over with NSTEMI, a selective invasive strategy guided by stress imaging was not non-inferior to routine invasive management for death, myocardial infarction or stroke at 12 months.

Risultato

Efficacia: MACCE (all-cause death, non-fatal myocardial infarction, non-fatal stroke) at 12 monthsHR 1,22 (IC 95% 0,86-1,72) · P = 0,27

Sotto 1 a favore di a selective invasive strategy guided by stress imaging, sopra 1 a favore di routine invasive management.

Tassi di eventi
Differenza assoluta
3,4 punti

La differenza assoluta è derivata dai tassi di eventi.

Riportato inoltre: Recruitment stopped for futility after 587 of the planned 1,756 patients. Death, myocardial infarction or stroke at one year occurred in , so non-inferiority was not shown. The selective strategy did reduce the number of angiograms and their attendant complications.

Pubblicazione originale
Sottotema
Elderly NSTEMI strategy
Disegno
Multicentre (France), open-label, 1:1 randomised, two-arm parallel non-inferiority trial; 12-month follow-up; non-inferiority declared if the upper limit of the one-sided 97.5% CI for the hazard ratio is <1.24 (7% absolute margin); registry status "terminated" after a planned interim analysis
Rilevanza
Importante: uno dei diversi pilastri.
Fonte
Barone-Rochette G, et al. Presented at ESC Congress 2026, Hot Line 11, 31 August.

Discussione e critica

Sparing the very old an angiogram is an attractive idea and this trial could not show it is safe: the point estimate ran the wrong way, the confidence interval reached 1.72, and the data monitors stopped enrolment at a third of target for futility. That is not proof of harm: 587 patients and 130-odd events leave room for a smaller difference either way, but it removes the argument that stress imaging first is a defensible default at 80 and over. What the strategy did buy is fewer catheterisations; whoever wants to trade procedures for a possible excess of events now has to say so explicitly.